CD4 Count Thresholds for Live Vaccines

Introduction to Live Vaccine Administration

The American College of Physicians and Infectious Diseases Society recommends that live vaccines should be avoided in HIV-infected patients when CD4 counts fall below 200 cells/mm³, with specific thresholds varying by age, as children require CD4 percentage ≥15%, while adults need absolute CD4 counts ≥200 cells/mm³ 1, 2

For HIV-infected adults, the critical threshold is CD4 count ≥200 cells/mm³ for live vaccine administration, according to the Infectious Diseases Society 3, 4
Yellow fever vaccine can be considered only in asymptomatic HIV-infected adults with CD4 counts ≥200 cells/mm³ when travel to endemic areas cannot be avoided, though it generally should not be administered to immunocompromised persons, as per the Centers for Disease Control and Prevention guidelines 3, 4
MMR vaccine should not be administered to HIV-infected patients aged ≥14 years with CD4 counts <200 cells/mm³, as recommended by the Infectious Diseases Society 5
Varicella vaccine (VAR) should only be given to varicella-nonimmune, clinically stable HIV-infected patients aged ≥14 years with CD4 counts ≥200 cells/mm³, with doses separated by ≥3 months, according to the American Academy of Pediatrics and Infectious Diseases Society guidelines 5

For HIV-infected children, CD4 percentage ≥15% is the key threshold for live vaccine administration, with age-specific absolute count requirements, as recommended by the American Academy of Pediatrics and Infectious Diseases Society 5
Children aged 1-8 years require CD4 percentage ≥15% for VAR administration, according to the Pediatric Infectious Diseases Society 5
Children aged 9-13 years require CD4 percentage ≥15% for VAR administration, as per the American Academy of Pediatrics guidelines 5
Children aged 9 months-5 years: Yellow fever vaccine can be considered if CD4 percentage ≥15% when travel to endemic areas is unavoidable, as recommended by the Centers for Disease Control and Prevention and Infectious Diseases Society 3, 4
MMR vaccine is safe in HIV-infected children with CD4 percentage ≥15%, but severe complications occurred in children with lower percentages, according to the Infectious Diseases Society 5

For patients with combined immunodeficiencies, the threshold is CD3 T-cell count ≥500 cells/mm³ for live vaccine consideration, as recommended by the Infectious Diseases Society and Clinical Immunology Society 1, 2, 6
Children with partial DiGeorge syndrome should receive MMR and VAR only if they have ≥500 CD3 T cells/mm³, ≥200 CD8 T cells/mm³, AND normal mitogen response, according to the Clinical Immunology Society and Infectious Diseases Society guidelines 1, 2, 7
Patients with SCID, complete DiGeorge syndrome with CD3 count <500 cells/mm³, Wiskott-Aldrich syndrome, or X-linked lymphoproliferative disease should avoid ALL live vaccines, as recommended by the Infectious Diseases Society and Clinical Immunology Society 1, 2, 6, 7

Live oral poliovirus vaccine (OPV) is absolutely contraindicated in major antibody deficiencies, according to the World Health Organization and Infectious Diseases Society guidelines 1, 7
Live attenuated influenza vaccine (LAIV) should not be given to HIV-infected patients, as recommended by the Centers for Disease Control and Prevention and Infectious Diseases Society 5
Quadrivalent MMR-varicella (MMRV) vaccine is contraindicated in HIV-infected patients, according to the American Academy of Pediatrics and Infectious Diseases Society guidelines 5
Yellow fever vaccine is generally contraindicated except in minimal immunosuppression as noted above, as per the Centers for Disease Control and Prevention guidelines 3, 4

Rotavirus vaccine is an important exception: HIV-exposed or HIV-infected infants should receive rotavirus vaccine according to the standard schedule for uninfected infants, as recommended by the American Academy of Pediatrics and Infectious Diseases Society 5
This recommendation applies regardless of CD4 count in infants, according to the Centers for Disease Control and Prevention guidelines 5
Rotavirus vaccine has been safely administered to HIV-infected infants, including those with CD4 percentages <25%, as per the Infectious Diseases Society guidelines 5

Ideally, all vaccines, especially live vaccines, should be administered at least 4 weeks before initiating immunosuppressive therapy, as recommended by the Infectious Diseases Society and Clinical Immunology Society 3, 4